GLP-1 for Adults 60-65

The 60-65 age range is a transitional period: approaching Medicare eligibility, potentially retiring, and wanting to ensure your health supports an active next chapter. Semaglutide and tirzepatide can improve mobility, reduce cardiovascular risk, and enhance quality of life.

Age-Appropriate Goals

Weight loss goals for adults 60-65 should focus on function over numbers:

• Improved mobility and reduced joint pain
• Cardiovascular risk reduction (the SELECT trial benefit)
• Reducing or eliminating medications
• Better sleep and energy for retirement activities
• Maintaining independence and functional strength

Managing Risks

• Sarcopenia: Muscle loss is the primary concern. Resistance training and high protein are mandatory
• Bone density: Weight loss can decrease bone density. Monitor with DEXA, supplement vitamin D and calcium
• Dehydration: Older adults have reduced thirst sensation. Set water intake reminders
• Falls: Changed center of gravity plus reduced muscle can increase fall risk. Include balance exercises
• Polypharmacy: GLP-1 delays gastric emptying, affecting absorption of other medications. Review timing with pharmacist

Medicare and Insurance at 60-65

• Under 65 (not yet Medicare): Private insurance or ACA marketplace plans may cover GLP-1 with prior authorization. Compounded options through Trimi are most affordable for self-pay
• At 65 (Medicare): Medicare Part D may cover Wegovy for CV risk reduction. Coverage varies by plan. Medicare Advantage plans may have additional coverage
• Medigap: Does not cover prescription drugs

The "Start Low, Go Slow" Approach

For adults 60-65, many providers recommend:

• Starting at the absolute lowest dose
• Extending time at each dose level (4-6 weeks instead of 4)
• Targeting the minimum effective dose rather than maximum
• Monitoring labs more frequently (every 3 months)
• Including body composition monitoring, not just weight

Frequently Asked Questions